Comparison of two kinds of magnetic nanoparticles in vivo and in vitro

Abstract

This study compared a new type of polysaccharide-coated magnetic nanoparticles (in which the polysaccharide is derived from Angelica sinensis) with the dextran magnetic nanoparticles in terms of preparation, biocompatibility and tissue distribution in vivo and in vitro in order to examine the potential application of Angelica polysaccharide as a novel carrier in magnetic drug targeting (MDT). Magnetic nanoparticles were prepared by chemical co-precipitation. Their physical and chemical properties were determined by using the transmission electron microscope (TEM), laser particle size analyzer (DLS) and vibrating sample magnetometer (VSM), and their purity and structure by using X-ray diffractometer (XRD) and Fourier transform infrared spectroscopy (FTIR). The atomic absorption spectrometric method was performed for quantification of the iron content in different tissues. Histological sections were stained by Prussian blue staining to observe the disposition of magnetic nanoparticles in the liver and kidney. The results showed that both kinds of magnetic nanoparticles possessed small particle size, good dispersion and good magnetic properties. XRD showed the main component of the two magnetic nanoparticles was Fe₃O₄ crystals, and FTIR proved Fe₃O₄ was successfully coated by each polysaccharide, respectively. In vivo, Fe₃O₄-dextran accumulated in the liver, spleen and lung and Fe₃O₄-Angelica polysaccharide only in the spleen and lung. It was concluded that Angelica polysaccharide may be applied as a novel carrier in the preparation of magnetic nanoparticles.

Keywords

Angelica polysaccharide / dextran / magnetic nanoparticles

References

[1] KrishnanS., DiagaradjaneP., ChoS.H., et al.. Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy. Int J Hyperthermia, 2010, 26(8): 775-789

[2] Hofmann-AmtenbrinkM., HofmannH., MontetX., et al.. Superparamagnetic nanoparticles—a tool for early diagnostics. Swiss Med Wkly, 2010, 140: w13081

[3] LiuS., JiaB., QiaoR., et al.. A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application. Mol Pharm, 2009, 6(4): 1074-1082

[4] OhW.K., YoonH., JangJ., et al.. Size control of magnetic carbon nanoparticles for drug delivery. Biomaterials, 2010, 31(6): 1342-1348

[5] ShangP., QianA.R., YangT.H., et al.. Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis. World J Gastroenterol, 2003, 9(9): 1963-1967

[6] CaoW., ZhouJ., WangY., et al.. Synthesis and in vitro cancer cell targeting of folate-functionalized biodegradable amphiphilic dendrimer-like star polymers. Biomacromolecules, 2010, 11(12): 3680-3687

[7] LacavaL.M., LacavaZ.G., DaS.M., et al.. Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. Biophys J, 2001, 80(5): 2483-2486

[8] RyanP.. Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis. J Hist Sex, 2010, 19(2): 317-339

[9] ZhangL.Y., ZhuX.J., SuH.W., et al.. Control synthesis of magnetic Fe₃O₄-chitosan nanoparticles under UV irradiation in aqueous system. Current Applied Physics, 2010, 10: 828-833

[10] ChangY.C., ChenD.H.. Preparation and adsorption properties of monodisperse chitosan-bound Fe₃O₄ magnetic nanoparticles for removal of Cu (II) ions. J Colloid Interface Sci, 2005, 283(2): 446-451

[11] CuiF., LiJ., DingA., et al.. Conditional QTL mapping for plant height with respect to the length of the spike and internode in two mapping populations of wheat. Theor Appl Genet, 2011, 122(8): 1517-1536

[12] BakerJ.H., LamJ., KyleA.H., et al.. Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin. Clin Cancer Res, 2008, 14(22): 7260-7271

[13] GongL.S., ZhangY.D., LiuS., et al.. Target distribution of magnetic albumin nanoparticles containing adriamycin in transplanted rat liver cancer model. Hepatobiliary Pancreat Dis Int, 2004, 3(3): 365-368

[14] MaH.L., XuY.F., QiX.R., et al.. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm, 2008, 354(1–2): 217-226

[15] DuguetE., VasseurS., MornetS., et al.. Towards a versatile platform based on magnetic nanoparticles for in vivo applications. Bull Mater Sci, 2006, 29(6): 581-586

[16] HuangB.R., ChenP.Y., HuangC.Y., et al.. Bioavailability of magnetic nanoparticles to the brain. Magn Magn Mater, 2009, 321: 1604-1609